Syndax Pharmaceuticals, Inc. · NASDAQ:SNDX
Point72 Asset Management, L.P. reported a 5.00% stake in Syndax Pharmaceuticals, Inc. (Schedule 13G)
Event Jan 21, 2025 · Filed Jan 22, 2025
Point72 Asset Management, L.P. reported a 5.00% stake in Syndax Pharmaceuticals, Inc., 4,277,847 shares, as a passive investor on Jan 21, 2025. Filed Jan 22, 2025 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 4,277,847
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 5.00% | 4,277,847 |
| Point72 Capital Advisors, Inc. | 5.00% | 4,277,847 |
| Steven A. Cohen | 5.00% | 4,277,847 |
Source
Related
- Syndax Pharmaceuticals, Inc.
- Point72 Asset Management, L.P.
- Syndax Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Aug 18, 2025
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2025
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Metzger Michael A · Jul 9, 2026
- Form 4 · Botwood Nicholas A.J. · Jun 12, 2026
- Form 4 · Goldan Keith A. · Jun 2, 2026
- Form 4 · Metzger Michael A · Jun 2, 2026